0 items USD 0.00Search
- Did you mean
- biological therapeutics
Your search for "biological therapies" gave back 50 results.
Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
June 2015
Price: USD 2,995.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
February 2023
Price: USD 2,000.00
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape Summary GBI Research’s latest report, "Stem Cell...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
July 2016
Price: USD 2,995.00
Men’s health refers to conditions that specifically affect males, or those that are not gender-specific but have different outcomes in men. Although...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
March 2015
Price: USD 2,995.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
November 2022
Price: USD 2,500.00
The global influenza vaccines market is projected to exceed US$ 9.5 Billion mark by 2027, and is presenting ample opportunities to the industry’s...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
iGATE
July 2021
Price: USD 2,590.00
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
January 2018
Price: USD 2,995.00
Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook Summary GBI Research’s latest report, "Gene Therapies: A...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
September 2015
Price: USD 2,995.00
The global high intensity focused ultrasound (HIFU) therapy market is likely to reach nearly US$ 525 Million by 2026. High intensity focused...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
iGATE
March 2020
Price: USD 1,890.00
T-Cell & NK-Cell Engaging Bispecific Antibo dies 2019: a business, stakeholder, technology and pipeline analysis report provides you with a...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
June 2019
Price: USD 2,700.00
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, “Innovation...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
May 2017
Price: USD 2,995.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
July 2022
Price: USD 2,000.00
Innovation Tracking Factbook 2016 - An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, "Innovation Tracking...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
June 2016
Price: USD 2,995.00
Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape Summary GBI Research's latest...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
March 2016
Price: USD 2,995.00
This report evaluates Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) from an industry perspective for its suitability as a tumor-specific...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
June 2022
Price: USD 1,170.00
Ìý
